RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 76 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2014. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $522,000 | +67.3% | 58,182 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $312,000 | +16.4% | 58,182 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $268,000 | -11.6% | 58,182 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $303,000 | -13.9% | 58,182 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $352,000 | -61.7% | 58,182 | 0.0% | 0.00% | -66.7% |
| Q2 2015 | $919,000 | +56.3% | 58,182 | +7.6% | 0.00% | +50.0% |
| Q1 2015 | $588,000 | +3.3% | 54,069 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $569,000 | +9.6% | 54,069 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $519,000 | -16.8% | 54,069 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $624,000 | +16.9% | 54,069 | +1.3% | 0.00% | 0.0% |
| Q1 2014 | $534,000 | -23.2% | 53,353 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $695,000 | -12.8% | 53,353 | 0.0% | 0.00% | -33.3% |
| Q3 2013 | $797,000 | +59.7% | 53,353 | 0.0% | 0.00% | +50.0% |
| Q2 2013 | $499,000 | – | 53,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|